Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | SNCA | P37840 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.38 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.38 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL845365 | 0.79 | ALDH1A1 (0.42) | HPGDHSD17B10CYP1A2TSHRMAPT | |
| SCHEMBL18317416 | 0.79 | ALDH1A1 (0.46) | HPGDHSD17B10CYP1A2TSHRTHRB | |
| SCHEMBL386939 | 0.77 | HSD17B10 (0.44) | HPGDHSD17B10CYP1A2TSHRMAPT | |
| SCHEMBL5031513 | 0.75 | ALDH1A1 (0.38) | HPGDHSD17B10CYP1A2TSHRMAPT | |
| SCHEMBL15271216 | 0.75 | ALDH1A1 (0.34) | HPGDHSD17B10CYP1A2TSHRMAPT | |
| SCHEMBL18317387 | 0.75 | CDK4 (0.40) | HPGDHSD17B10CYP1A2TSHRMAPT | |
| SCHEMBL380657 | 0.74 | CYP1A2 (0.65) | HPGDHSD17B10CYP1A2TSHRMAPT | |
| SCHEMBL4598235 | 0.73 | PTPN22 (0.44) | HPGDHSD17B10CYP1A2TSHRMAPT | |
| SCHEMBL25108 | 0.72 | ALDH1A1 (0.55) | HPGDHSD17B10CYP1A2TSHRMAPT | |
| SCHEMBL16107752 | 0.72 | CYP1A2 (0.56) | HPGDHSD17B10CYP1A2TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1483582-B1 | DISSOCIATIVE FLUORESCENCE ENHANCEMENT ASSAY | WALLAC OY (FI) | 2008-04-16 | — | — | EP | claimed |
| US-7345172-B2 | Methods and compositions for detecting polynucleotide duplex damage and errors | CALFORNIA INSTITUTE OF TECHNOLOGY (US) | 2008-03-18 | — | — | US | claimed |
| EP-1483582-A1 | DISSOCIATIVE FLUORESCENCE ENHANCEMENT ASSAY | WALLAC OY (FI) | 2004-12-08 | — | — | EP | claimed |
| WO-2003076939-A1 | DISSOCIATIVE FLUORESCENCE ENHANCEMENT ASSAY | WALLAC OY (FI) | 2003-09-18 | — | — | WO | claimed |
| US-20030170907-A1 | Dissociative fluorescence enhancement assay | WALLAC OY (FI) | 2003-09-11 | — | — | US | claimed |
| EP-2841943-B1 | METHOD FOR CHARACTERIZING AND/OR DETERMINING SAMPLES | KEMIRA OYJ (FI) | 2023-09-27 | — | — | EP | disclosed |
| US-20160258936-A1 | METHOD FOR ANALYZING GAS SAMPLES | TURUN YLIOPISTO (FI) | 2016-09-08 | — | — | US | disclosed |
| WO-2015059363-A1 | METHOD FOR ANALYZING GAS SAMPLES | TURUN YLIOPISTO (FI) | 2015-04-30 | — | — | WO | disclosed |
| US-20150094234-A1 | Method for characterizing and/or determining samples | AQSENS OY (FI) | 2015-04-02 | — | — | US | disclosed |
| EP-2841943-A1 | METHOD FOR CHARACTERIZING AND/OR DETERMINING SAMPLES | Aqsens Oy (FI) | 2015-03-04 | — | — | EP | disclosed |
| WO-2013160547-A1 | METHOD FOR CHARACTERIZING AND/OR DETERMINING SAMPLES | HAERMAE HARRI (FI) | 2013-10-31 | — | — | WO | disclosed |
| US-7381567-B2 | Dissociative fluorescence enhancement assay | WALLAC OY (FI) | 2008-06-03 | — | — | US | disclosed |
| EP-1483582-A1 | DISSOCIATIVE FLUORESCENCE ENHANCEMENT ASSAY | WALLAC OY (FI) | 2004-12-08 | — | — | EP | disclosed |
| US-6808884-B2 | INTERCALATION COMPOUND FOR USE IN THE DIAGNOSIS AND DETECTION OF GENETIC DISORDERS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2004-10-26 | — | — | US | disclosed |
| WO-2002057492-A9 | METHODS AND COMPOSITIONS FOR DETECTING POLYNUCLEOTIDE DUPLEX DAMAGE | CALIFORNIA INST OF TECHN (US) | 2003-12-18 | — | — | WO | disclosed |
| EP-1349962-A1 | METHODS AND COMPOSITIONS FOR DETECTING POLYNUCLEOTIDE DUPLEX DAMAGE | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-10-08 | — | — | EP | disclosed |
| WO-2003076939-A1 | DISSOCIATIVE FLUORESCENCE ENHANCEMENT ASSAY | WALLAC OY (FI) | 2003-09-18 | — | — | WO | disclosed |
| US-20030170907-A1 | Dissociative fluorescence enhancement assay | WALLAC OY (FI) | 2003-09-11 | — | — | US | disclosed |
| US-20020155470-A1 | Methods and compositions for detecting polynucleotide duplex damage and errors | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2002-10-24 | — | — | US | disclosed |
| WO-2002057492-A1 | METHODS AND COMPOSITIONS FOR DETECTING POLYNUCLEOTIDE DUPLEX DAMAGE | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020155470-A1 | Methods and compositions for detecting polynucleotide duplex damage and errors | POLRMT, POLN, POLM | HPGD 2904/4885HSD17B10 2144/4885CYP1A2 3537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.